Patents Assigned to Ricerfarma S.R.L.
  • TOPICAL COMPOSITIONS DESIGNATED TO MAINTAIN AND/OR RESTORE THE INTEGRITY OF THE MUCOSA AND DAMAGED EPIDERMIS
    Publication number: 20240024352
    Abstract: Disclosed are topical mucoadhesive compositions comprising hyaluronic acid or a salt thereof, choline alfoscerate, an ascorbic acid ester at a concentration ranging between 0.050% w/w and 0.0004% w/w, and at least one pharmaceutically acceptable excipient or carrier.
    Type: Application
    Filed: September 29, 2023
    Publication date: January 25, 2024
    Applicant: RICERFARMA S.R.L.
    Inventor: Roberto Cerini
  • TOPICAL ANTIVIRAL COMPOSITIONS COMPRISING HYALURONIC ACID AND CARRAGEENAN
    Publication number: 20230355657
    Abstract: Disclosed are topical compositions comprising hyaluronic acid or salts thereof and iota-carrageenan, preferably in a mucoadhesive matrix containing ascorbyl palmitate and choline alfoscerate. The compositions according to the invention are useful for topical treatment of Herpesvirus infections.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 9, 2023
    Applicant: RICERFARMA S.R.L.
    Inventor: Roberto Cerini
  • TOPICAL COMPOSITIONS DESIGNATED TO MAINTAIN AND/OR RESTORE THE INTEGRITY OF THE MUCOSA AND DAMAGED EPIDERMIS
    Publication number: 20230114487
    Abstract: Disclosed are topical mucoadhesive compositions comprising hyaluronic acid or a salt thereof, choline alfoscerate, an ascorbic acid ester at a concentration ranging between 0.050% w/w and 0.0004% w/w, and at least one pharmaceutically acceptable excipient or carrier.
    Type: Application
    Filed: February 25, 2021
    Publication date: April 13, 2023
    Applicant: RICERFARMA S.R.L.
    Inventor: Roberto Cerini
  • Combinations for oral compositions, their preparation and use
    Patent number: 9987214
    Abstract: A composition having a pH in the range of from 3 to 8.5, comprising: (a) in the range of from 0.1% to <10% w/w (based on the total weight of the composition) of a stock solution comprising a mixture of bioflavonoids and fruit acids or salts thereof; (b) sodium hyaluronate; and (c) water; and, optionally, (d) a pharmaceutically acceptable carrier therefor; wherein the sodium hyaluronate has an average molecular weight of between 800,000 and 4,000,000.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: June 5, 2018
    Assignees: Oraldent Limited, Ricerfarma S.R.L.
    Inventors: Ian Ripley, Howard Thomas
  • Combinations for oral compositions, their preparation and use
    Patent number: 9532939
    Abstract: A composition having a pH in the range of from 3 to 8.5, comprising: (a) in the range of from 0.1% to <10% w/w (based on the total weight of the composition) of a stock solution comprising a mixture of bioflavonoids and fruit acids or salts thereof; (b) sodium hyaluronate; and (c) water; and, optionally, (d) a pharmaceutically acceptable carrier therefor; wherein the sodium hyaluronate has an average molecular weight of between 800,000 and 4,000,000.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: January 3, 2017
    Assignees: Ricerfarma S.R.L., Oraldent Limited
    Inventors: Ian Ripley, Howard Thomas
  • TOPICAL COMPOSITIONS DESIGNED TO MAINTAIN OR RESTORE THE INTEGRITY OF THE MUCOUS MEMBRANES
    Publication number: 20120135087
    Abstract: The present invention relates to topical compositions containing choline alfoscerate for use in maintaining and restoring the integrity of the mucous membranes.
    Type: Application
    Filed: March 11, 2011
    Publication date: May 31, 2012
    Applicant: RICERFARMA S.R.L.
    Inventor: Michele Giuseppe Di Schiena
  • Compound compositions with improved analgesic antipyretic and anti-inflammatory activity
    Patent number: 4859658
    Abstract: Pharmaceutical compositions containing thioacetamol and an amount of a non-steroidal anti-inflammatory drug selected from aspirin, indomethacin, dichlofenac, naproxen, sulindac and fenbufen potentiate the activity of these drugs and reduce their undesiderable side-effects.
    Type: Grant
    Filed: February 29, 1988
    Date of Patent: August 22, 1989
    Assignees: Ricerfarma S.R.L., Life Science Research Israel Ltd
    Inventors: Michele G. Di Schiena, Zvi Paster